1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Horizon Discovery Ltd.

Have updates for this profile?  Please contribute data

About Deals
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2005

Location

Cambridge UK

Primary Industry

Biotechnology

About

Founded in 2005 and based in the UK, Horizon Discovery Ltd. is a biotechnology company that provides research tools of gene editing and gene modulation in the global life science market that helps scientists in producing medicines and therapies.
Current Investors
Molten Ventures, MVM Partners, Roche Venture Fund

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.horizondiscovery.com
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only

Deals

Deals Type
Trade Sale
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Sage Labs 29 Sep 2014
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo